It has a certain inhibitory effect on the pain response of mice, promotes the absorption of peritoneal blood clots in mice and rabbits, inhibits uterine inflammation in rats, has an in vitro antibacterial effect on Candida albicans, Trichophyton and other bacteria, has an in vivo antibacterial effect on Staphylococcus aureus, and shows anti-inflammatory effects on croton oil ear swelling in mice and foot swelling in rats

This product is a blood lipid regulating drug of clofibric acid derivatives. It reduces blood low-density lipoprotein, cholesterol and triglycerides by inhibiting the production of very low-density lipoprotein and triglycerides and increasing their catabolism at the same time; it also increases the production of apolipoprotein A1 and A11, thereby increasing high-density lipoprotein. This product also has the effect of reducing blood uric acid in normal people and patients with hyperuricemia. Animal experiments have shown that fenofibrate is teratogenic and carcinogenic.

In vivo, the original drug and intermediate metabolite with cytotoxic effect act on the DNA of anaerobic bacteria, amoeba, Giardia and Trichomonas cells, breaking their helical structure or blocking their transcription and replication, thus causing their death, achieving the purpose of antibacterial antigen.